“Risperidone Versus Quetiapine: Risk of Developing Metabolic Syndromes in Patients Suffering from Psychiatry Disorders of a Health Care Center”. 2020. Asian Journal of Pharmaceutical and Health Sciences 10 (3): 2309-17. https://doi.org/10.5530/1a3vgq24.